Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024
GlobeNewswire
*Allschwil, Switzerland, May 03, 2024*
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage..
European Society of Clinical Microbiology and Infectious Diseases
News and Video Search Results
News coverage
-
SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID)
GlobeNewswire
-
Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024
GlobeNewswire
-
ESCMID: грипп обладает высоким потенциалом пандемии
PRAVDA
-
Globalists programming ChatGPT to “reduce vaccine hesitancy” by parroting public health narratives
NaturalNews.com
0 shares
1 views
You might like
European Society of Clinical Microbiology and Infectious Diseases media coverage
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global) 2024
GlobeNewswire
BOSTON, April 18, 2024 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on providing..
-
Media Advisory: DoseMe Bioinformatician and Chief Science and Strategy Officer Co-Author Abstract Big Data Bayesian Truths to Be Covered in Oral Presentation at the 24th ECCMID Annual Meeting
Business Wire
-
Basilea announces that FDA approves expanded use of antifungal Cresemba® (isavuconazole) in the United States in children with invasive aspergillosis and invasive mucormycosis
GlobeNewswire
-
ABL Diagnostics expands its commercial network and collaborations to offer unique Sanger & NGS based microbiology genotyping assays and software worldwide.
Pressat
-
Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
GlobeNewswire
Advertisement
More coverage
In Vitro Diagnostics Market Assessment, By Product Type, By Techniques, By Settings, By Application, By End-user, By Region, Opportunities and Forecast, 2016-2030F
GlobeNewswire
In Vitro Diagnostics Market Assessment, By Product Type [Instruments, Reagents and Consumables, Data Management Software], By..
-
Valneva Announces Successful Outcome of its AGM and the Appointment of Pfizer’s Former Vaccine R&D Head to its Supervisory Board
GlobeNewswire
-
AIM ImmunoTech Appoints Preeminent Biotechnology Pioneer, W. Neal Burnette, Ph.D., as Chairman of its Scientific Advisory Board (SAB)
GlobeNewswire
-
Everest Medicines Announces Approval of Xerava in China for the Treatment of Complicated Intra-Abdominal Infections in Adult Patients
PR Newswire Asia
-
Not Enough New Antibiotics In The Pipeline, Concludes WHO Review
Eurasia Review